Navigation Links
Kendle to Present at the 2008 Credit Suisse Health Care Conference

CINCINNATI, Nov. 11 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) a leading, global full-service clinical research organization, today announced Senior Vice President and Chief Financial Officer Karl "Buzz" Brenkert III will participate in the annual Credit Suisse Health Care Conference. The conference will be held at the Arizona Biltmore Resort & Spa in Phoenix, Nov. 11-14, 2008. Kendle's presentation is scheduled for Friday, Nov. 14 at 10 a.m. Mountain Time (12 p.m. Eastern Standard Time).

(Logo: )

The public is invited to listen to a live Webcast of Kendle's presentation at (click on the link provided in the Investor Events and Presentations section). An archived version can be accessed approximately three hours following Kendle's presentation and will be available until Dec. 15. Slides accompanying the presentation will be available by 9:00 a.m. Eastern Standard Time on Nov. 14 at under the Investor Events and Presentations section.
Following is a direct link to the Credit Suisse Webcast:

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008. The company also has been recognized as "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
2. Kendle Named a Best Place to Work in Greater Cincinnati
3. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
4. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast
7. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
8. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
9. Kendle Appoints Patricia Williams Vice President, Commercial Operations
10. Kendle Invites You to Attend its First Quarter 2008 Earnings Conference Call and Webcast
11. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
(Date:11/24/2015)... 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual ... 11:00 a.m. Israel time, at the law offices ... Street, 36 th Floor, Tel Aviv, Israel . ... and Izhak Tamir to the Board of Directors; , ... , approval of an amendment to certain terms of options granted ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list of ... OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic ...
(Date:11/24/2015)... , November 24, 2015 , ... a European healthcare fund ... companies will work closely together in identifying European breakthrough technologies ... need. The collaboration is underpinned by a significant investment by ... is the first investment by Bristol-Myers Squibb in a European ...
Breaking Biology Technology:
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
(Date:11/9/2015)... Nov. 09, 2015 ... of the "Global Law Enforcement Biometrics ... --> ) has announced ... Enforcement Biometrics Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:10/29/2015)...  The J. Craig Venter Institute (JCVI) policy group ... Biosecurity: Lessons Learned and Options for the Future," which ... Services guidance for synthetic biology providers has worked since ... --> --> Synthetic biology promises great ... pose unique biosecurity threats. It now is easier than ...
Breaking Biology News(10 mins):